Securing investment has become an uphill battle for privately held digital health companies amidst challenging conditions. Nevertheless, Merck Global Health Innovation Fund President, Bill Taranto, delivered a ray of hope to entrepreneurs at the prestigious Global Global Corporate Venturing Symposium. Taranto outlined five strategic actions that, if followed, can greatly enhance the chances of success for companies seeking funding in this demanding landscape.
In the first quarter of 2023, 10% of all corporate venture capital rounds raised by Europe-based companies were down rounds, which is the highest percentage since 2020, PitchBook data unveiled by Mr. Taranto showed. Over the same period, Europe-based companies raised $10.4 billion, which is far below the $29.5 billion raised in the first quarter of 2022 and the $22.3 billion raised in Q1 of 2021, according to an analysis by CB Insights.